Learn more

BAYLOR RES INST

Overview
  • Total Patents
    715
  • GoodIP Patent Rank
    16,134
  • Filing trend
    ⇩ 60.0%
About

BAYLOR RES INST has a total of 715 patent applications. It decreased the IP activity by 60.0%. Its first patent ever was published in 1988. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ID BIOMEDICAL CORP, SHENZHEN BINDE BIO TECH CO LTD and BAYLOR RES INSTITUTE.

Patent filings per year

Chart showing BAYLOR RES INSTs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Banchereau Jacques F 339
#2 Zurawski Gerard 172
#3 Palucka Anna Karolina 106
#4 Oh Sangkon 98
#5 Zurawski Sandra 96
#6 Chaussabel Damien 70
#7 Goel Ajay 46
#8 Flamar Anne-Laure 43
#9 Boland C Richard 41
#10 Pascual Maria Virginia 39

Latest patents

Publication Filing date Title
CN112154217A Methods and compositions for treating, diagnosing and prognosing ovarian cancer
WO2017168348A1 Angiopoietin-like protein 8 (angptl8)
WO2017132563A1 Joint disorder diagnosis with 3d motion capture
WO2016186926A1 Treatment protocol based on patient motion
WO2016164303A1 METHODS FOR DIAGNOSING AND TREATING COLORECTAL CANCER USING snoRNA
WO2016160880A1 Methods and compositions for treating pancreatitis
WO2016160882A1 Methods for diagnosing and treating colorectal cancer using mirna549a
US2017296438A1 Intraluminal tubes with deployable structures and related methods
US2017249854A1 Systems and methods for virtual learning environments
WO2015200094A1 Methods and compositions for systemic lupus erythematosus (sle) therapy
CN106456736A Methods and compositions for treating allergy and inflammatory diseases
EP3094652A1 Novel vaccines against hpv and hpv-related diseases
US2015166655A1 Anti-interferon alpha monoclonal antibodies and methods of use
CA2874065A1 Methods and compositions for treating breast cancer with dendritic cell vaccines
EP3065706A1 Nuclear localization of glp-1 stimulates myocardial regeneration and reverses heart failure
CA2905949A1 Ulcerative colitis (uc)-associated colorectal neoplasia markers
WO2014160363A1 Surface modification of porcine islets
WO2014150900A1 Methods and compositions for enhanced analyte detection from blood
WO2014127038A1 Methods and compositions related to calcium homeostasis and fabry disease
EP2931923A1 Blood transcriptional signatures of active pulmonary tuberculosis and sarcoidosis